| Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials PE Sax, KM Erlandson, JE Lake, GA Mccomsey, C Orkin, S Esser, ... Clinical Infectious Diseases 71 (6), 1379-1389, 2020 | 579 | 2020 |
| Metabolic disease in HIV infection JE Lake, JS Currier The Lancet infectious diseases 13 (11), 964-975, 2013 | 213 | 2013 |
| Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large … K Bourgi, CA Jenkins, PF Rebeiro, BE Shepherd, F Palella, RD Moore, ... Journal of the International AIDS Society 23 (4), e25484, 2020 | 191 | 2020 |
| Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors DR Bakal, LE Coelho, PM Luz, JL Clark, RB De Boni, SW Cardoso, ... Journal of Antimicrobial Chemotherapy 73 (8), 2177-2185, 2018 | 172 | 2018 |
| HIV and antiretroviral therapy-related fat alterations JR Koethe, C Lagathu, JE Lake, P Domingo, A Calmy, J Falutz, TT Brown, ... Nature reviews Disease primers 6 (1), 48, 2020 | 165 | 2020 |
| Regulatory T Cell Expansion in HTLV-1 and Strongyloidiasis Co-infection Is Associated with Reduced IL-5 Responses to Strongyloides stercoralis Antigen M Montes, C Sanchez, K Verdonck, JE Lake, E Gonzalez, G Lopez, ... PLoS neglected tropical diseases 3 (6), e456, 2009 | 157 | 2009 |
| Risk factors for weight gain following switch to integrase inhibitor–based antiretroviral therapy JE Lake, K Wu, SH Bares, P Debroy, C Godfrey, JR Koethe, ... Clinical Infectious Diseases 71 (9), e471-e477, 2020 | 150 | 2020 |
| Dolutegravir/abacavir/lamivudine versus current ART in virally suppressed patients (STRIIVING): a 48-week, randomized, non-inferiority, open-label, phase IIIb study B Trottier, JE Lake, K Logue, C Brinson, L Santiago, C Brennan, JA Koteff, ... Antiviral therapy 22 (4), 295-305, 2017 | 140 | 2017 |
| Vitamin D in HIV-infected patients JE Lake, JS Adams Current Hiv/aids Reports 8, 133-141, 2011 | 115 | 2011 |
| The fat of the matter: obesity and visceral adiposity in treated HIV infection JE Lake Current HIV/AIDS Reports 14, 211-219, 2017 | 100 | 2017 |
| Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL … NG Sandler, X Zhang, RJ Bosch, NT Funderburg, AI Choi, JK Robinson, ... The Journal of infectious diseases 210 (10), 1549-1554, 2014 | 90 | 2014 |
| Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study JE Lake, D Wohl, R Scherzer, C Grunfeld, PC Tien, S Sidney, JS Currier AIDS care 23 (8), 929-938, 2011 | 84 | 2011 |
| Long-term body composition changes in antiretroviral-treated HIV-infected individuals PM Grant, D Kitch, GA McComsey, AC Collier, B Bartali, SL Koletar, ... Aids 30 (18), 2805-2813, 2016 | 83 | 2016 |
| Inaccuracy of haemoglobin A1c among HIV-infected men: effects of CD4 cell count, antiretroviral therapies and haematological parameters L Slama, FJ Palella Jr, AG Abraham, X Li, C Vigouroux, G Pialoux, ... Journal of Antimicrobial Chemotherapy 69 (12), 3360-3367, 2014 | 79 | 2014 |
| Inflammation, immune activation, immunosenescence, and hormonal biomarkers in the frailty-related phenotype of men with or at risk for HIV infection KM Erlandson, DK Ng, LP Jacobson, JB Margolick, AS Dobs, FJ Palella Jr, ... The Journal of infectious diseases 215 (2), 228-237, 2017 | 73 | 2017 |
| Weight change following antiretroviral therapy switch in people with viral suppression: pooled data from randomized clinical trials KM Erlandson, CC Carter, K Melbourne, TT Brown, C Cohen, M Das, ... Clinical Infectious Diseases 73 (8), 1440-1451, 2021 | 72 | 2021 |
| Practical review of recognition and management of obesity and lipohypertrophy in human immunodeficiency virus infection JE Lake, TL Stanley, CM Apovian, S Bhasin, TT Brown, J Capeau, ... Clinical Infectious Diseases 64 (10), 1422-1429, 2017 | 71 | 2017 |
| Risk of incident diabetes mellitus, weight gain, and their relationships with integrase inhibitor–based initial antiretroviral therapy among persons with human immunodeficiency … PF Rebeiro, CA Jenkins, A Bian, JE Lake, K Bourgi, RD Moore, ... Clinical Infectious Diseases 73 (7), e2234-e2242, 2021 | 70 | 2021 |
| Abdominal obesity, sarcopenia, and osteoporosis are associated with frailty in men living with and without HIV KL Hawkins, L Zhang, DK Ng, KN Althoff, FJ Palella Jr, LA Kingsley, ... Aids 32 (10), 1257-1266, 2018 | 70 | 2018 |
| Vitamin D3 supplementation in HIV infection: effectiveness and associations with antiretroviral therapy L Coelho, SW Cardoso, PM Luz, RM Hoffman, L Mendonça, VG Veloso, ... Nutrition journal 14, 1-9, 2015 | 67 | 2015 |
